Scientists test drug interactions for future schizophrenia treatment
NCT ID NCT07305779
Summary
This study tested how a potential new schizophrenia medication (SEP-380135) might interact with other drugs in the body. Researchers gave healthy adult participants the study drug along with another medication that affects how drugs are processed. The goal was to understand potential safety issues before testing in people with schizophrenia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dr. Vince Clinical Research
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.